National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Chinese Center for Tropical Diseases Research, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Key Laboratory of Parasite and Vector Biology, Ministry of Health, 207 Ruijin Er Road, Shanghai, 200025, People's Republic of China.
Infect Dis Poverty. 2019 Aug 7;8(1):66. doi: 10.1186/s40249-019-0578-9.
The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was launched in response to the call proposed at the 50th World Health Assembly. The goal of the GPELF is to ensure that all the countries where the disease is endemic would have been transmission-free or would have entered post-intervention mass drug administration (MDA) surveillance by 2020. However, several countries are still not on track to discontinue MDA as planned. Thus, issues remain regarding the achievement of stated goals and how to effectively monitor the disease in the post-control and post-elimination phases.
China was once a lymphatic filariasis (LF) endemic country with heavy disease burden. There were three milestones in the LF control phase of China, including: the proposal that the major focus of the control strategy should be on infectious sources; the three regimens of diethylcarbamazine (DEC) administration according to LF endemic extent; and the establishment of the threshold for LF transmission interruption. It has been ten years since China entered the post-elimination stage (declaration of LF elimination in China was in 2007). Two schemes and a diagnostic criterion were issued to guide all levels of disease control and prevention workers that conduct LF surveillance, as well as those caring for chronic filariasis patients. Regular training courses are held to maintain LF control skills in grass-root institutions. The Notifiable Diseases Reporting System, which included LF in 2004, plays an important role in LF post-elimination surveillance. Until now, no resurgence of LF cases has been detected, except for LF residue foci being found in Fuchuan County of the Guangxi Zhuang Autonomous Region. To confirm that transmission is no longer achievable after a decade since the declaration of LF elimination in China, it is expected within the next two years a transmission assessment survey, conducted in previous LF-endemic areas.
DEC-fortified salt can help accelerate the progress of GPELF before the sprite phase. Sophisticated diagnostic criteria, systematic surveillance regimes, the Direct Network Report system, and regular trainings can effectively prevent the recrudescence of LF during surveillance phases.
全球消灭淋巴丝虫病规划(GPELF)是应第 50 届世界卫生大会提议而启动的。该规划的目标是确保所有流行该病的国家到 2020 年无传播或进入干预后大规模药物治疗(MDA)监测。然而,仍有几个国家尚未按计划停止 MDA。因此,在实现既定目标方面和如何在控制后和消除后阶段有效监测该病方面仍存在问题。
中国曾是淋巴丝虫病(LF)流行国家,疾病负担沉重。中国 LF 控制阶段有三个里程碑,包括:建议控制策略的主要重点应放在感染源上;根据 LF 流行程度制定的三种乙胺嗪(DEC)治疗方案;以及确定 LF 传播中断阈值。自中国进入消除后阶段(2007 年宣布 LF 消除)以来,已经十年了。发布了两个方案和一个诊断标准,以指导各级疾病控制和预防工作人员开展 LF 监测以及照顾慢性丝虫病患者。定期举办培训班以保持基层机构的 LF 控制技能。自 2004 年包括 LF 在内的传染病报告系统在 LF 消除后监测中发挥了重要作用。到目前为止,除了在广西壮族自治区富川县发现 LF 残留病灶外,没有发现 LF 病例的复发。为了确认中国宣布 LF 消除十年后是否不再可能发生传播,预计在未来两年内将在以前的 LF 流行地区进行传播评估调查。
强化盐 DEC 可帮助在精灵阶段之前加速 GPELF 的进展。复杂的诊断标准、系统的监测方案、直接网络报告系统和定期培训可在监测阶段有效防止 LF 的复发。